BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $33,000 | -93.8% | 33,000 | -93.5% | 0.00% | – |
| Q1 2020 | $536,000 | +73.5% | 506,000 | +68.7% | 0.00% | – |
| Q3 2019 | $309,000 | +415.0% | 300,000 | +500.0% | 0.00% | – |
| Q3 2018 | $60,000 | -20.0% | 50,000 | -26.5% | 0.00% | – |
| Q1 2018 | $75,000 | -93.4% | 68,000 | -92.9% | 0.00% | -100.0% |
| Q1 2017 | $1,137,000 | -44.5% | 963,000 | -44.9% | 0.00% | -50.0% |
| Q4 2016 | $2,050,000 | -61.7% | 1,749,000 | -59.3% | 0.00% | -60.0% |
| Q3 2016 | $5,353,000 | +76371.4% | 4,293,000 | +71450.0% | 0.01% | – |
| Q1 2016 | $7,000 | -97.2% | 6,000 | -96.8% | 0.00% | – |
| Q4 2015 | $249,000 | -86.3% | 186,000 | -86.2% | 0.00% | -100.0% |
| Q3 2015 | $1,813,000 | -33.5% | 1,349,000 | -25.1% | 0.00% | -33.3% |
| Q1 2015 | $2,726,000 | +4159.4% | 1,800,000 | +3361.5% | 0.00% | – |
| Q4 2014 | $64,000 | -94.0% | 52,000 | -94.7% | 0.00% | -100.0% |
| Q3 2014 | $1,075,000 | +834.8% | 982,000 | +844.2% | 0.00% | – |
| Q1 2014 | $115,000 | +59.7% | 104,000 | +55.2% | 0.00% | – |
| Q4 2013 | $72,000 | – | 67,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|